Table of Contents Author Guidelines Submit a Manuscript
Mediators of Inflammation
Volume 2015, Article ID 163140, 11 pages
http://dx.doi.org/10.1155/2015/163140
Research Article

Histone Deacetylase Inhibitor Trichostatin A Ameliorated Endotoxin-Induced Neuroinflammation and Cognitive Dysfunction

1Department of Medical Research, Chi Mei Medical Center, Tainan 710, Taiwan
2Department of Anesthesiology, Chi Mei Medical Center, Tainan 710, Taiwan
3Department of Anesthesiology, Taipei Medical University, Taipei 110, Taiwan
4Department of Radiation Oncology, Buddhist Dalin Tzu Chi General Hospital, Chiayi 622, Taiwan
5School of Medicine, Tzu Chi University, Hualien 970, Taiwan
6Department of Surgery, Chi Mei Medical Center, Tainan 710, Taiwan
7Department of Medicinal Botanicals and Health Applications, Da-Yeh University, Changhua 515, Taiwan

Received 6 January 2015; Revised 25 March 2015; Accepted 25 March 2015

Academic Editor: Zhengyuan Xia

Copyright © 2015 Chung-Hsi Hsing et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. Y. Xu, J. Yan, P. Zhou et al., “Neurotransmitter receptors and cognitive dysfunction in Alzheimer's disease and Parkinson's disease,” Progress in Neurobiology, vol. 97, no. 1, pp. 1–13, 2012. View at Publisher · View at Google Scholar · View at Scopus
  2. Y. Wan, J. Xu, D. Ma, Y. Zeng, M. Cibelli, and M. Maze, “Postoperative impairment of cognitive function in rats: a possible role for cytokine-mediated inflammation in the hippocampus,” Anesthesiology, vol. 106, no. 3, pp. 436–443, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. N. Terrando, C. Monaco, D. Ma, B. M. J. Foxwell, M. Feldmannc, and M. Maze, “Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 47, pp. 20518–20522, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. J. C. M. Schlachetzki and M. Hüll, “Microglial activation in Alzheimer's disease,” Current Alzheimer Research, vol. 6, no. 6, pp. 554–563, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. M. C. Morganti-Kossmann, L. Satgunaseelan, N. Bye, and T. Kossmann, “Modulation of immune response by head injury,” Injury, vol. 38, no. 12, pp. 1392–1400, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. K. W. Kelley, R. M. Bluthé, R. Dantzer et al., “Cytokine-induced sickness behavior,” Brain, Behavior, and Immunity, vol. 17, supplement 1, pp. S112–S118, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Dantzer and K. W. Kelley, “Twenty years of research on cytokine-induced sickness behavior,” Brain, Behavior, and Immunity, vol. 21, no. 2, pp. 153–160, 2007. View at Publisher · View at Google Scholar · View at Scopus
  8. L. L. Skalisz, V. Beijamini, S. L. Joca, M. A. B. F. Vital, C. Da Cunha, and R. Andreatini, “Evaluation of the face validity of reserpine administration as an animal model of depression-Parkinson's disease association,” Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 26, no. 5, pp. 879–883, 2002. View at Publisher · View at Google Scholar · View at Scopus
  9. F. Frenois, M. Moreau, J. O'Connor et al., “Lipopolysaccharide induces delayed FosB/DeltaFosB immunostaining within the mouse extended amygdala, hippocampus and hypothalamus, that parallel the expression of depressive-like behavior,” Psychoneuroendocrinology, vol. 32, no. 5, pp. 516–531, 2007. View at Publisher · View at Google Scholar · View at Scopus
  10. J. Abraham, S. Jang, J. P. Godbout et al., “Aging sensitizes mice to behavioral deficits induced by central HIV-1 gp120,” Neurobiology of Aging, vol. 29, no. 4, pp. 614–621, 2008. View at Publisher · View at Google Scholar · View at Scopus
  11. T. K. S. Craft and A. C. DeVries, “Role of IL-1 in poststroke depressive-like behavior in mice,” Biological Psychiatry, vol. 60, no. 8, pp. 812–818, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Layé, P. Parnet, E. Goujon, and R. Dantzer, “Peripheral administration of lipopolysaccharide induces the expression of cytokine transcripts in the brain and pituitary of mice,” Molecular Brain Research, vol. 27, no. 1, pp. 157–162, 1994. View at Publisher · View at Google Scholar · View at Scopus
  13. R. Dantzer, J. C. O'Connor, G. G. Freund, R. W. Johnson, and K. W. Kelley, “From inflammation to sickness and depression: when the immune system subjugates the brain,” Nature Reviews Neuroscience, vol. 9, no. 1, pp. 46–56, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. J. Chen, J. B. Buchanan, N. L. Sparkman, J. P. Godbout, G. G. Freund, and R. W. Johnson, “Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system,” Brain, Behavior, and Immunity, vol. 22, no. 3, pp. 301–311, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. Y. Huang, C. J. Henry, R. Dantzer, R. W. Johnson, and J. P. Godbout, “Exaggerated sickness behavior and brain proinflammatory cytokine expression in aged mice in response to intracerebroventricular lipopolysaccharide,” Neurobiology of Aging, vol. 29, no. 11, pp. 1744–1753, 2008. View at Publisher · View at Google Scholar · View at Scopus
  16. J. P. Godbout, M. Moreau, J. Lestage et al., “Aging exacerbates depressive-like behavior in mice in response to activation of the peripheral innate immune system,” Neuropsychopharmacology, vol. 33, no. 10, pp. 2341–2351, 2008. View at Publisher · View at Google Scholar · View at Scopus
  17. G. A. Garden and T. Möller, “Microglia biology in health and disease,” Journal of Neuroimmune Pharmacology, vol. 1, no. 2, pp. 127–137, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. A. D. Kraft and G. J. Harry, “Features of microglia and neuroinflammation relevant to environmental exposure and neurotoxicity,” International Journal of Environmental Research and Public Health, vol. 8, no. 7, pp. 2980–3018, 2011. View at Publisher · View at Google Scholar · View at Scopus
  19. K. Saijo and C. K. Glass, “Microglial cell origin and phenotypes in health and disease,” Nature Reviews Immunology, vol. 11, no. 11, pp. 775–787, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. A. Fischer, F. Sananbenesi, A. Mungenast, and L.-H. Tsai, “Targeting the correct HDAC(s) to treat cognitive disorders,” Trends in Pharmacological Sciences, vol. 31, no. 12, pp. 605–617, 2010. View at Publisher · View at Google Scholar · View at Scopus
  21. C. L. Peterson and M.-A. Laniel, “Histones and histone modifications,” Current Biology, vol. 14, no. 14, pp. R546–R551, 2004. View at Publisher · View at Google Scholar · View at Scopus
  22. V. Kannan, N. Brouwer, U.-K. Hanisch, T. Regen, B. J. L. Eggen, and H. W. G. M. Boddeke, “Histone deacetylase inhibitors suppress immune activation in primary mouse microglia,” Journal of Neuroscience Research, vol. 91, no. 9, pp. 1133–1142, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. S. J. Shuttleworth, S. G. Bailey, and P. A. Townsend, “Histone Deacetylase inhibitors: new promise in the treatment of immune and inflammatory diseases,” Current Drug Targets, vol. 11, no. 11, pp. 1430–1438, 2010. View at Publisher · View at Google Scholar · View at Scopus
  24. H.-S. Suh, S. Choi, P. Khattar, N. Choi, and S. C. Lee, “Histone deacetylase inhibitors suppress the expression of inflammatory and innate immune response genes in human microglia and astrocytes,” Journal of Neuroimmune Pharmacology, vol. 5, no. 4, pp. 521–532, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Halili, M. R. Andrews, L. I. Labzin et al., “Differential effects of selective HDAC inhibitors on macrophage inflammatory responses to the Toll-like receptor 4 agonist LPS,” Journal of Leukocyte Biology, vol. 87, no. 6, pp. 1103–1114, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. H. J. Kim, M. Rowe, M. Ren, J. S. Hong, P. S. Chen, and D. M. Chuang, “Histone deacetylase inhibitors exhibit anti-inflammatory and neuroprotective effects in a rat permanent ischemic model of stroke: multiple mechanisms of action,” Journal of Pharmacology and Experimental Therapeutics, vol. 321, no. 3, pp. 892–901, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. I. M. Adcock, “HDAC inhibitors as anti-inflammatory agents,” British Journal of Pharmacology, vol. 150, no. 7, pp. 829–831, 2007. View at Publisher · View at Google Scholar · View at Scopus
  28. J.-L. Bret-Dibat and R. Dantzer, “Cholecystokinin receptors do not mediate the suppression of food- motivated behavior by lipopolysaccharide and interleukin-1 beta in mice,” Physiology and Behavior, vol. 69, no. 3, pp. 325–331, 2000. View at Publisher · View at Google Scholar · View at Scopus
  29. J. M. Levenson, K. J. O'Riordan, K. D. Brown, M. A. Trinh, D. L. Molfese, and J. D. Sweatt, “Regulation of histone acetylation during memory formation in the hippocampus,” The Journal of Biological Chemistry, vol. 279, no. 39, pp. 40545–40559, 2004. View at Publisher · View at Google Scholar · View at Scopus
  30. J.-S. Guan, S. J. Haggarty, E. Giacometti et al., “HDAC2 negatively regulates memory formation and synaptic plasticity,” Nature, vol. 459, no. 7243, pp. 55–60, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. C. L. Benn, R. Butler, L. Mariner et al., “Genetic knock-down of HDAC7 does not ameliorate disease pathogenesis in the R6/2 mouse model of Huntington's disease,” PLoS ONE, vol. 4, no. 6, Article ID e5747, 2009. View at Publisher · View at Google Scholar · View at Scopus
  32. N. M. Tsankova, O. Berton, W. Renthal, A. Kumar, R. L. Neve, and E. J. Nestler, “Sustained hippocampal chromatin regulation in a mouse model of depression and antidepressant action,” Nature Neuroscience, vol. 9, no. 4, pp. 519–525, 2006. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Peleg, F. Sananbenesi, A. Zovoilis et al., “Altered histone acetylation is associated with age-dependent memory impairment in mice,” Science, vol. 328, no. 5979, pp. 753–756, 2010. View at Publisher · View at Google Scholar · View at Scopus
  34. J. M. Rubio-Perez and J. M. Morillas-Ruiz, “A review: inflammatory process in Alzheimer's disease, role of cytokines,” The Scientific World Journal, vol. 2012, Article ID 756357, 15 pages, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. A.-M. van Dam, M. Brouns, S. Louisse, and F. Berkenbosch, “Appearance of interleukin-1 in macrophages and in ramified microglia in the brain of endotoxin-treated rats: a pathway for the induction of non-specific symptoms of sickness?” Brain Research, vol. 588, no. 2, pp. 291–296, 1992. View at Publisher · View at Google Scholar · View at Scopus
  36. R. Dantzer, “Cytokine-induced sickness behavior: where do we stand?” Brain, Behavior, and Immunity, vol. 15, no. 1, pp. 7–24, 2001. View at Publisher · View at Google Scholar · View at Scopus
  37. J. C. O'Connor, M. A. Lawson, C. André et al., “Lipopolysaccharide-induced depressive-like behavior is mediated by indoleamine 2,3-dioxygenase activation in mice,” Molecular Psychiatry, vol. 14, no. 5, pp. 511–522, 2009. View at Publisher · View at Google Scholar · View at Scopus
  38. D. R. Walkinshaw and X.-J. Yang, “Histone deacetylase inhibitors as novel anticancer therapeutics,” Current Oncology, vol. 15, no. 5, pp. 70–76, 2008. View at Google Scholar · View at Scopus
  39. K. Iwata, K. Tomita, H. Sano, Y. Fujii, A. Yamasaki, and E. Shimizu, “Trichostatin A, a histone deacetylase inhibitor, down-regulates interleukin-12 transcription in SV-40-transformed lung epithelial cells,” Cellular Immunology, vol. 218, no. 1-2, pp. 26–33, 2002. View at Publisher · View at Google Scholar · View at Scopus
  40. R. Glauben, A. Batra, I. Fedke et al., “Histone hyperacetylation is associated with amelioration of experimental colitis in mice,” Journal of Immunology, vol. 176, no. 8, pp. 5015–5022, 2006. View at Publisher · View at Google Scholar · View at Scopus